AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$3.94
+0.02 (+0.51%)
Open$3.95
Previous Close$3.92
Day High$4.04
Day Low$3.87
52W High$7.55
52W Low$2.93
Volume—
Avg Volume2.14M
Market Cap492.46M
P/E Ratio—
EPS$-0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+557.4% upside
Current
$3.94
$3.94
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.52M | 56.80M | 128.94M |
| Net Income | -104,435,737 | -96,145,829 | 33.13M |
| Profit Margin | -188.1% | -178.7% | 25.7% |
| EBITDA | -87,882,752 | -85,401,610 | 53.66M |
| Free Cash Flow | — | — | 23.71M |
| Rev Growth | -2.2% | -2.2% | +19.1% |
| Debt/Equity | 4.68 | 4.68 | 0.57 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |